<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03252613</url>
  </required_header>
  <id_info>
    <org_study_id>1050374</org_study_id>
    <nct_id>NCT03252613</nct_id>
  </id_info>
  <brief_title>Translational Approaches to Septic Cardiomyopathy</brief_title>
  <acronym>TASC01</acronym>
  <official_title>Translational Approaches to Septic Cardiomyopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samuel Brown</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Euan Ashley</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Intermountain Health Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This translational study will assess the association between septic cardiomyopathy (measured
      via left ventricular global longitudinal strain) and (a) inflammatory cytokine profiles, and
      (b) the behavior of cardiomyocytes derived from inducible pluripotent stem cells.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 19, 2017</start_date>
  <completion_date type="Anticipated">October 27, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 27, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of cytokine profile with left ventricular global longitudinal strain</measure>
    <time_frame>Day 1</time_frame>
    <description>This outcome assesses the correlation between inflammatory cytokines (summarized via PCA) and septic cardiomyopathy, as assessed by left ventricular global longitudinal strain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adrenergic susceptibility of pluripotent stem cell-derived cardiomyocytes</measure>
    <time_frame>Day 1</time_frame>
    <description>This is a laboratory-based outcome, using pluripotent stem cell-derived cardiomyocytes, with exposure to adrenergic agonists and antagonists in vitro</description>
  </secondary_outcome>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Cardiomyopathies</condition>
  <condition>Sepsis</condition>
  <condition>Septic Shock</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The population of study subjects must be 18 years of age, admitted to an ICU and have
        sepsis or septic shock as defined in the above inclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        INCLUSION CRITERIA

        At least 18 years of age Admitted to the ICU

        SEPSIS PATIENTS:

        Sepsis patients must have:

          1. Suspected or confirmed infection AND

          2. Organ dysfunction as defined by a SOFA &gt;= 2 above baseline (if no baseline data
             available, SOFA assumed to be 0)

        OR

        SEPTIC SHOCK PATIENTS:

        AFTER INFUSION OF 20ML/KG CRYSTALLOID OR EQUIVALENT, septic shock patients must have:

          1. Suspected or confirmed infection AND

          2. Lactate &gt; 2 mmol/L AND

          3. Receiving vasopressors

        EXCLUSION CRITERIA Known pregnancy Primary diagnosis of acute coronary syndrome Known
        preexisting heart disease Known severe valvular disease (regurgitation or stenosis)

        Major cardiac dysrhythmia such as:

          -  Ventricular tachycardia (V-tach)

          -  Ventricular Fibrillation (V-fib)

          -  Third degree heart block (complete hear block or complete AV block)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samuel Brown, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intermountain Health Care, Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Euan Ashley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samuel Brown, MD</last_name>
    <phone>801-507-4710</phone>
    <email>Samuel.Brown@imail.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katie Brown</last_name>
    <phone>801-507-4582</phone>
    <email>Katie.Brown@imail.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Euan Ashley, MD</last_name>
      <phone>650-736-7878</phone>
      <email>euan@stanford.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Intermoutain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samuel Brown, MD</last_name>
      <phone>801-507-4710</phone>
      <email>samuel.brown@imail.org</email>
    </contact>
    <contact_backup>
      <last_name>Katie Brown</last_name>
      <phone>801-507-4582</phone>
      <email>katie.brown@imail.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2017</study_first_submitted>
  <study_first_submitted_qc>August 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2017</study_first_posted>
  <last_update_submitted>August 15, 2017</last_update_submitted>
  <last_update_submitted_qc>August 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Intermountain Health Care, Inc.</investigator_affiliation>
    <investigator_full_name>Samuel Brown</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>septic cardiomyopathy</keyword>
  <keyword>cytokine</keyword>
  <keyword>iPSC</keyword>
  <keyword>Inducible pluripotent stem cell</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>There will be a database/tissue bank for future research</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

